Investigator Initiated Studies (IIS) supports external, non-commercial sponsors conducting independent clinical, observational, real-world evidence, and health outcomes research to explore scientific questions.
Investigator-Initiated Research (IIR) supports independent investigators’ preclinical, clinical, outcomes, and disease-state studies that address scientific questions and unmet patient needs.
Investigator Initiated Studies (IIS) Program supports independent investigators and institutions studying Eisai products and compounds to address medical or scientific questions in neurology and oncology.
Investigator Initiated Studies (IIS) supports investigators and research sponsors conducting clinical studies to deepen understanding of Genentech medicines, improve patient care, and inspire disease research.
Investigator-Initiated Studies supports independent researchers through Sarepta Therapeutics funding or study materials to answer medical and scientific questions in rare neuromuscular diseases.